Hepatitis C virus infection among noninjecting drug users in New York City

Journal of Medical Virology

Volumn 70, Issue 3, 2003, Pages 387-390

  Koblin, Beryl A ^a   Factor, Stephanie H ^b,c   Wu, Yingfeng ^c   Vlahov, David ^c  

^a NEW YORK BLOOD CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Drug users; Epidemiology; Hepatitis C virus; Risk behaviors

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; SEROLOGY; SNIFFING; UNITED STATES;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; COCAINE; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HEROIN DEPENDENCE; HUMANS; MALE; NEW YORK CITY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SUBSTANCE-RELATED DISORDERS;

HEPATITIS C VIRUS;

EID: 0038024230     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10407     Document Type: Article

References (35)

1. Abraham HD, Degli-Esposti S, Marino L. 1999. Seroprevalence of hepatitis C in a sample of middle class substance abusers. J Addict Dis 18:77-87.
2. Alter MJ, Mast EE, Moyer LA, Margolis HS. 1998. Hepatitis C. Infect Dis Clin North Am 12:13-26.
3. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562.
4. Baozhang T, Kaining Z, Jinxing K, Ruchang X, Ming L, Caixia Z, Li T. 1997. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts. Epidemiol Infect 119:343-347.
5. Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K. 1990. Hepatitis C virus in intravenous drug users. Med J Aust 153:274-276.
6. Centers for Disease Control and Prevention. 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 47:1-39.
7. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW. 1996. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334:1691-1696.
8. Coppola RC, Masia G, di Martino ML, Carboni G, Muggianu E, Piro R, Manconi PE. 1996. Sexual behaviour and multiple infections in drug abusers. Eur J Epidemiol 12:429-435.
9. Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, Torian L, Glebatis D, Murrill C, Monterroso E, Friedman SR. 2000a. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 90:352-359.
10. Des Jarlais D, Perlis T, Friedman SR, Chapman T, Kwok J, Rockwell R, Paone D, Milliken J, Monterroso E. 2000b. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health 90:1112-1116.
11. Diaz T, Des J, Vlahov D, Perlis TE, Edwards V, Friedman SR, Rockwell R, Hoover D, Williams IT, Monterroso ER. 2001. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 91:23-30.
12. Donahue JG, Nelson KE, Munoz A, Vlahov D, Rennie LL, Taylor EL, Saah AJ, Cohn S, Odaka NJ, Farzadegan H. 1991. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 134:1206-1211.
13. Feldman JG, Minkoff H, Landesman S, Dehovitz J. 2000. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm Dis 27:338-342.
14. Fingerhood MI, Jasinski DR, Sullivan JT. 1993. Prevalence of hepatitis C in a chemically dependent population. Arch Intern Med 153:2025-2030.
15. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. 1996. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 86:655-661.
16. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. 1998. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 18(suppl 1):S11-S19.
17. Girardi E, Zaccarelli M, Tossini G, Puro V, Narciso P, Visco G. 1990. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis 22:751-752.
18. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais D. 2002. Risk correlates of prevalent HIV, hepatitis b virus, and hepatitis c virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr 30:448-456.
19. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. 2001. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 91:42-46.
20. Hershow RC, Kalish LA, Sha B, Till M, Cohen M. 1998. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis 25:527-532.
21. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ. 2000. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 31:756-762.
22. Nyamathi AM, Dixon EL, Robbins W, Smith C, Wiley D, Leake B, Longshore D, Gelberg L. 2002. Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med 17:134-143.
23. Page-Shafer KA, Cahoon-Young B, Klausner JD, Morrow S, Molitor F, Ruiz J, McFarland W. 2002. Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health 92:670-676.
24. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, Constantine NT, Wolford GL, Salyers MP. 2001. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 91:31-37.
25. Santana Rodriguez OE, Male Gil ML, Hernandez Santana JF, Liminana Canal JM, Martin Sanchez AM. 1998. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 14:555-561.
26. Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN. 2000. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J Health Popul Nutr 18:145-150.
27. Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. 1995a. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 74:212-220.
28. Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, Quinn TC. 1995b. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - an analysis of 309 sex partnerships. J Infect Dis 171:768-775.
29. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS. 2002. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 155:645-653.
30. Tortu S, Neaigus A, McMahon J, Hagen D. 2001. Hepatitis C among noninjecting drug users: a report. Subst Use Misuse 36:523-534.
31. Van Ameijden EJ, Van den Hoek JA, Mientjes GH, Coutinho RA. 1993. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 9:255-262.
32. Van den Hoek JA, van Haastrecht HJ, Goudsmit J, de Wolf F, Coutinho RA. 1990. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 162:823-826.
33. Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. 1997. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 35:3274-3277.
34. Wada K, Greberman SB, Konuma K, Hirai S. 1999. HIV and HCV infection among drug users in Japan. Addiction 94:1063-1069.
35. Ward H, Pallecaros A, Green A, Day S. 2000. Health issues associated with increasing use of "crack" cocaine among female sex workers in London. Sex Transm Infect 76:292-293.